MBA with Professional Certificate in Clinical Trial Protocols

Monday, 04 May 2026 10:39:10

International Students can apply

Apply Now     Viewbook

MBA with Professional Certificate in Clinical Trial Protocols

Overview

Clinical Trial Protocols

is designed for professionals seeking to enhance their knowledge in the pharmaceutical industry. This MBA with Professional Certificate program focuses on the development, implementation, and management of clinical trial protocols.
Some key aspects of the program include understanding regulatory requirements, designing effective trial protocols, and ensuring compliance with industry standards. The course also covers topics such as clinical trial management, data analysis, and quality assurance.
By completing this program, learners will gain a deeper understanding of the clinical trial process and be able to apply their knowledge in real-world settings.
If you're interested in advancing your career in the pharmaceutical industry, explore this MBA with Professional Certificate in Clinical Trial Protocols to learn more.

Clinical Trial Protocols are the backbone of modern medical research, and our MBA with Professional Certificate in Clinical Trial Protocols is designed to equip you with the expertise to navigate this complex landscape. This course offers key benefits such as enhanced career prospects in the pharmaceutical and biotechnology industries, as well as the ability to design and implement effective clinical trial protocols. With a unique blend of business and scientific knowledge, you'll gain a competitive edge in the job market. Our program also covers regulatory compliance and data analysis, ensuring you're equipped to succeed in this field. (4)

Entry requirements

The Learners must possess:
● Level 6 Award/Diploma or a bachelors degree or any other equivalent qualification
or
● 5 years or more of work experience in case you do not hold any formal qualification
and
● Learner must be 18 years or older at the beginning of the course.



International Students can apply

Joining our world will be life-changing with a student body representing over 157 nationalities.

LSIB is truly an international institution with history of welcoming students from around the world. With us, you're not just a student, you're a member.

Course Content


• Clinical Trial Design and Planning •
• Good Clinical Practice (GCP) Regulations •
• Clinical Trial Protocol Development •
• Regulatory Affairs in Clinical Trials •
• Clinical Trial Management Systems (CTMS) •
• Study Start-Up and Initiation •
• Data Management and Quality Assurance •
• Clinical Trial Monitoring and Audits •
• Study Close-Out and Reporting

Assessment

The evaluation process is conducted through the submission of assignments, and there are no written examinations involved.

Fee and Payment Plans

30 to 40% Cheaper than most Universities and Colleges

Duration

The programme is available in two duration modes:

12 Months: GBP £7700
18 Months: GBP £6700
This programme does not have any additional costs.
The fee is payable in monthly, quarterly, half yearly instalments.
You can avail 5% discount if you pay the full fee upfront in 1 instalment

Payment plans

12 Months - GBP £7700

● Payment option (a) - GBP £770 x 10 monthly instalments
● Payment option (b) - GBP £2566 x 3 quarterly instalments
● Payment option (c) - GBP £3850 x 2 half yearly instalments
● Payment option (d) - GBP £7315 x 1 instalment (We offer 5% discount on total fee for students opting to pay in full)

18 Months - GBP £6700

● Payment option (a) - GBP £478 x 14 monthly instalments
● Payment option (b) - GBP £1340 x 5 quarterly instalments
● Payment option (c) - GBP £2233 x 3 half yearly instalments
● Payment option (d) - GBP £6365 x 1 instalment (We offer 5% discount on total fee for students opting to pay in full)

Our course fee is upto 40% cheaper than most universities and colleges.

Apply Now

Accreditation

Stage 1 (Delivered by LSIB):
The programme involves delivery through on-line Learning Management System (LMS). This stage leads to award of Level 7 Diploma in Strategic Management and Leadership. Credits earned at this stage - 120 credits (60 ECTS).

Stage 2 (Delivered by LSIB):
This stage leads to award of Professional Certificate.

Stage 3 (Delivered by the University / awarding body)
On completion of the diploma programme you progress / Top up with Degree through a UK University for progression to the MBA degree. The stage 3 is delivered via distance learning by faculties from the University / awarding body. Credits earned at this stage - 60 credits (30 ECTS).

Apply Now

  • 1. Complete the online enrolment form and Pay enrolment fee of GBP £10.
  • 2. Wait for our email with course start dates and fee payment plans. Your course starts once you pay the course fee.
  • Apply Now

Got questions? Get in touch

Chat with us: Click the live chat button

+44 75 2064 7455

admissions@lsib.co.uk

+44 (0) 20 3608 0144



Career path

Key facts about MBA with Professional Certificate in Clinical Trial Protocols

The MBA with Professional Certificate in Clinical Trial Protocols is a unique and specialized program designed to equip students with the knowledge and skills required to succeed in the pharmaceutical industry.
This program combines the rigors of an MBA with the specialized training needed to navigate the complex world of clinical trials.
By the end of the program, students will have gained a deep understanding of clinical trial protocols, regulatory compliance, and industry standards.
They will also develop essential business skills, including project management, marketing, and finance, to enable them to drive business growth and success in the pharmaceutical sector.
The program is designed to be completed in a relatively short duration of 12-18 months, making it an ideal option for working professionals who want to upskill and reskill in this field.
The industry relevance of this program is high, with many pharmaceutical companies and contract research organizations (CROs) actively seeking professionals with expertise in clinical trial protocols.
Graduates of this program will be in high demand, with opportunities available in a range of roles, including clinical trial management, regulatory affairs, and business development.
The program is also highly relevant to the growing field of medical devices and biotechnology, where clinical trial protocols are increasingly important.
Overall, the MBA with Professional Certificate in Clinical Trial Protocols is an excellent choice for anyone looking to launch or advance a career in the pharmaceutical industry.

Why this course?

The significance of an MBA with a Professional Certificate in Clinical Trial Protocols cannot be overstated in today's market. According to a recent survey by the Association of British Clinical Research Organisations (ABMRO), the demand for clinical trial professionals in the UK is expected to increase by 15% by 2025, with the average salary ranging from £60,000 to £100,000 per annum.
Year Growth Rate
2020 10%
2021 12%
2022 15%

Who should enrol in MBA with Professional Certificate in Clinical Trial Protocols?

Ideal Audience for MBA with Professional Certificate in Clinical Trial Protocols Are you a healthcare professional, business leader, or academic looking to bridge the gap between business and clinical research?
Key Characteristics: Professionals with a strong interest in clinical trials, pharmaceutical industry, and healthcare management, particularly those in the UK.
Target Audience Statistics: In the UK, the pharmaceutical industry employs over 70,000 people, with the clinical trials sector accounting for a significant portion of this workforce. With the UK's life sciences sector valued at £134 billion, there is a growing demand for professionals with expertise in clinical trial protocols.
Ideal Background: A bachelor's degree in a relevant field, such as life sciences, business, or healthcare, and at least 2 years of work experience in a related field.
Learning Objectives: Gain a comprehensive understanding of clinical trial protocols, develop business acumen, and enhance career prospects in the pharmaceutical industry.